# PITAVASTATIN CALCIUM
> **ANDA205932** · Abbreviated New Drug Application (Generic) · Sponsor: ORIENT PHARMA CO LTD · Approved 2017-02-03
## Drug
- **FDA Application Number:** ANDA205932
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** PITAVASTATIN CALCIUM
- **Generic name:** PITAVASTATIN CALCIUM
- **Active ingredients:** PITAVASTATIN CALCIUM
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ORIENT PHARMA CO LTD
- **Manufacturer:** Teva Pharmaceuticals, Inc.
- **First approval:** 2017-02-03
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205932)
---
*AI Analytics · CC0 1.0*